VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has closed on an aggregate of Euro 5.0 million (approximately $5.5 million) in financing from Wallonie Entreprendre S.A. ("WE") in Belgium.
Company Information
Company
VolitionRx
Location
Henderson, Nevada, United States
About
VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. The company is focused on advancing the science of epigenetics and developing simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis.
Fundz sees it the moment VolitionRx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
HendersonBiotechnologyHealth CareGeneticsTherapeutics